By expenditures
| Name | Title | Type |
|---|---|---|
| Matt Roy | Chief Financial Officer | Auditee |
| Emanuel Kuntzelman | FOUNDER AND CHIEF ADVISOR | Auditee |
| John Fedus | PARTNER | Auditee |
| John Fedus | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 344596 | 2024 | 2025-03-04 | Cherry Bekaert LLP | $1.20M |
| 326064 | 2023 | 2024-10-28 | Cherry Bekaert LLP | $1.66M |
| 33337 | 2022 | 2023-09-28 | Pkf Mueller | $1.37M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 344596 | 2024 | 2025-03-04 | 1101961 | 2024-002 | - | Yes | AB |
| 344596 | 2024 | 2025-03-04 | 1101960 | 2024-002 | - | Yes | AB |
| 344596 | 2024 | 2025-03-04 | 525519 | 2024-002 | - | Yes | AB |
| 344596 | 2024 | 2025-03-04 | 525518 | 2024-002 | - | Yes | AB |
| 326064 | 2023 | 2024-10-28 | 1080241 | 2023-004 | Material Weakness | - | G |
| 326064 | 2023 | 2024-10-28 | 1080240 | 2023-003 | Material Weakness | - | AB |
| 326064 | 2023 | 2024-10-28 | 1080239 | 2023-002 | Significant Deficiency | - | C |
| 326064 | 2023 | 2024-10-28 | 1080238 | 2023-001 | Material Weakness | Yes | L |
| 326064 | 2023 | 2024-10-28 | 1080237 | 2023-004 | Material Weakness | - | G |
| 326064 | 2023 | 2024-10-28 | 1080236 | 2023-003 | Material Weakness | - | AB |
| 326064 | 2023 | 2024-10-28 | 1080235 | 2023-002 | Significant Deficiency | - | C |
| 326064 | 2023 | 2024-10-28 | 1080234 | 2023-001 | Material Weakness | Yes | L |
| 326064 | 2023 | 2024-10-28 | 503799 | 2023-004 | Material Weakness | - | G |
| 326064 | 2023 | 2024-10-28 | 503798 | 2023-003 | Material Weakness | - | AB |
| 326064 | 2023 | 2024-10-28 | 503797 | 2023-002 | Significant Deficiency | - | C |
| 326064 | 2023 | 2024-10-28 | 503796 | 2023-001 | Material Weakness | Yes | L |
| 326064 | 2023 | 2024-10-28 | 503795 | 2023-004 | Material Weakness | - | G |
| 326064 | 2023 | 2024-10-28 | 503794 | 2023-003 | Material Weakness | - | AB |
| 326064 | 2023 | 2024-10-28 | 503793 | 2023-002 | Significant Deficiency | - | C |
| 326064 | 2023 | 2024-10-28 | 503792 | 2023-001 | Material Weakness | Yes | L |
| 33337 | 2022 | 2023-09-28 | 612942 | 2022-003 | Material Weakness | - | L |
| 33337 | 2022 | 2023-09-28 | 36500 | 2022-003 | Material Weakness | - | L |